Eastwood Bio-Medical Canada Inc.

EBM.VTSXVConsumer Defensive● Active

$0.95

+$0.09(+10.47%)

Market Cap$65441671

P/E Ratio—

52W High$1.1

52W Low$0.295

Avg Volume4K

Open$0.86

Beta0.14

Overview

Eastwood Bio-Medical Canada Inc. (EBM.V) Revenue

Annual & quarterly revenue history · segment & region breakdown

EBM.V · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

Eastwood Bio-Medical Canada Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 11.40% year-over-year from $0.00B in FY2025.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+11.40%

vs FY2025 $0.00B

Price / sales

90.94×

mktCap ÷ TTM rev

Revenue per day

$0M

Est. TTM ÷ 365

Revenue / employee

—

0 employees

FY2025

$0.00B

FY2024

$0.00B

5Y CAGR

+-4.4%

Fiscal year end

Dec 31

Currency

CAD · GAAP

Filing

10-K / 10-Q

Source: FMP · Eastwood Bio-Medical Canada Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

2025 – 2013 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2025-10-31	$0.00B	+$0.00B	+11.40%
2024-10-31	$0.00B	-$0.00B	-19.11%
2023-10-31	$0.00B	-$0.00B	-33.22%
2022-10-31	$0.00B	+$0.00B	+32.49%
2021-10-31	$0.00B	+$0.00B	+36.57%
2020-10-31	$0.00B	-$0.00B	-44.44%
2019-10-31	$0.00B	+$0.00B	+73.78%
2018-10-31	$0.00B	+$0.00B	+55.08%
2017-10-31	$0.00B	+$0.00B	+3.40%
2016-10-31	$0.00B	-$0.00B	-60.89%

EBM.V revenue by year · EBM.V revenue history · EBM.V annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Eastwood Bio-Medical Canada Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Eastwood Bio-Medical Canada Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.

Data sourced from Eastwood Bio-Medical Canada Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

EBM.V revenue · 4 questions

EBM.V's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 11.40% year-over-year from $0.00B in FY2025.

EBM.V revenueEBM.V annual revenuewhat is EBM.V revenueEBM.V TTM revenue

▸ Source: FMP · Eastwood Bio-Medical Canada Inc. SEC filings · GAAP · Eastwood Bio-Medical Canada Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026